Panacea Index Logo

Command Palette

Search for a command to run...

2:1 ketogenic diet and low-glycemic-index diet for the treatment of chronic and episodic migraine: a single-center real-life retrospective study.

The journal of headache and pain
July 28, 2023
Yan Tereshko et al. (13 authors)
Journal ArticleHuman Study
Study Details

Study Goal

The researchers aimed to evaluate the efficacy of a Low-Glycemic-Index Diet in reducing migraine symptoms and related disability in patients with chronic and high-frequency episodic migraine.

Results Summary

The study found that the Low-Glycemic-Index Diet improved migraine intensity, frequency, MIDAS and HIT-6 scores, as well as anthropometric measurements like fat mass, weight, and BMI. Both diets showed effectiveness in reducing migraine symptoms and disability.

Population

Sixty patients with high-frequency episodic and chronic migraine (39 on the Low-Glycemic-Index Diet).

Effective Dosage

Not specified

Duration

3 months

Interactions

None mentioned

Extracted Claims (14)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Low-Glycemic-index diet
decrease
migraine intensity
patients with high-frequency episodic and chronic migraine
-
improved
#1
Low-Glycemic-index diet
decrease
migraine frequency
patients with high-frequency episodic and chronic migraine
-
improved
#2
Low-Glycemic-index diet
decrease
MIDAS scores
patients with high-frequency episodic and chronic migraine
-
improved
#3
Low-Glycemic-index diet
decrease
HIT-6 scores
patients with high-frequency episodic and chronic migraine
-
improved
#4
Low-Glycemic-index diet
decrease
fat mass
patients with high-frequency episodic and chronic migraine
-
improved
#5
Low-Glycemic-index diet
decrease
weight
patients with high-frequency episodic and chronic migraine
-
improved
#6
Low-Glycemic-index diet
decrease
BMI
patients with high-frequency episodic and chronic migraine
-
improved
#7
2:1 ketogenic diet
decrease
migraine intensity
patients with high-frequency episodic and chronic migraine
-
improved
#8
2:1 ketogenic diet
decrease
migraine frequency
patients with high-frequency episodic and chronic migraine
-
improved
#9
2:1 ketogenic diet
decrease
MIDAS scores
patients with high-frequency episodic and chronic migraine
-
improved
#10
2:1 ketogenic diet
decrease
HIT-6 scores
patients with high-frequency episodic and chronic migraine
-
improved
#11
2:1 ketogenic diet
decrease
fat mass
patients with high-frequency episodic and chronic migraine
-
improved
#12
2:1 ketogenic diet
decrease
weight
patients with high-frequency episodic and chronic migraine
-
improved
#13
2:1 ketogenic diet
decrease
BMI
patients with high-frequency episodic and chronic migraine
-
improved
#14
Abstract

AIMS: The evidence supporting the efficacy of dietary preventive therapy in migraine is rising, particularly regarding the ketogenic diet. However, less evidence exists for the Low-Glycemic Index Diet and the 2:1 KD. This retrospective single-center real-life study aims to evaluate the efficacy of a 2:1 ketogenic diet and a Low-Glycemic-index Diet in chronic and high-frequency episodic migraine. METHODS: Sixty patients with high-frequency episodic and chronic migraine were treated with either a Low-Glycemic-index diet (39 patients) or a 2:1 (21 patients) ketogenic diet for three months. We collected data on the migraine frequency and intensity and the MIDAS and HIT-6 scores through the headache diary. Anthropometric measurements (BMI, fat mass, free fat mass, and weight) were also collected and analyzed similarly. Data obtained at the baseline and after three months of each diet were compared. RESULTS: Migraine intensity, frequency, MIDAS and HIT-6 scores, fat mass, weight, and BMI improved in both diet groups. CONCLUSIONS: Both diets are effective in reducing migraine symptoms and migraine-related disability.

Medical Subject Headings (MeSH)
HumansRetrospective StudiesDiet, KetogenicGlycemic IndexMigraine DisordersDiet
Study Links
Quality Scores
SafetyNot Assessed
Efficacy80/10
Quality65/10
Citation Metrics
Total Citations13
Citations/Year6.5
Relative Citation Ratio3.98
NIH Percentile90.1%
Research Impact Scores
APT Score0.75
Weight Score2.54
Normalized Score0.65
Related Supplements